Table 4.
Significantly down-regulated pathways in normal HMEC in response to oxidative stress and during cancer malignancy progression. Selection of pathways was based on Fisher Exact p-value. Annotation categories with p-value ≤ 0.05, were considered strongly enriched in down-regulated genes.
| KEGG Categories | HMEC GluOx response | HMLER-1 cancer progression | HMLER-5 cancer progression |
|---|---|---|---|
| hsa04520:Adherens junction | 0.000 | 0.000 | 0.000 |
| hsa04120:Ubiquitin mediated proteolysis | 0.000 | 0.000 | 0.000 |
| hsa04510:Focal adhesion | 0.001 | 0.003 | 0.003 |
| hsa04530:Tight junction | 0.003 | 0.000 | 0.001 |
| hsa05211:Renal cell carcinoma | 0.003 | 0.033 | 0.017 |
| hsa04350:TGF-beta signaling pathway | 0.004 | 0.003 | 0.003 |
| hsa04360:Axon guidance | 0.034 | 0.005 | 0.003 |
| hsa04010:MAPK signaling pathway | 0.036 | 0.033 | 0.024 |
| hsa05212:Pancreatic cancer | 0.037 | 0.049 | 0.039 |
| hsa04210:Apoptosis | 0.009 | * | * |
| hsa04115:p53 signaling pathway | 0.009 | * | * |
| hsa04070:Phosphatidylinositol signaling system | 0.013 | * | * |
| hsa05222:Small cell lung cancer | 0.025 | * | * |
| hsa05215:Prostate cancer | 0.025 | * | * |
| hsa04540:Gap junction | 0.032 | * | * |
| hsa01040:Polyunsaturated fatty acid biosynthesis | 0.016 | 0.032 | * |
| hsa00600:Sphingolipid metabolism | * | 0.006 | 0.006 |
| hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis | * | 0.013 | 0.013 |
| hsa04330:Notch signaling pathway | * | 0.013 | 0.014 |
| hsa04310:Wnt signaling pathway | * | * | 0.024 |
Not statistically significantly represented category based on Fisher Exact p-value.